RT Journal Article
SR Electronic
T1 Novel Machine-Learned Approach for COVID-19 Resource Allocation: A Tool for Evaluating Community Susceptibility
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.14.20212571
DO 10.1101/2020.10.14.20212571
A1 Neil Kale
YR 2020
UL http://medrxiv.org/content/early/2020/10/16/2020.10.14.20212571.abstract
AB Despite worldwide efforts to develop an effective COVID vaccine, it is quite evident that initial supplies will be limited. Therefore, it is important to develop methods that will ensure that the COVID vaccine is allocated to the people who are at major risk until there is a sufficient global supply. Herein, I developed a machine-learning tool that could be applied to assess the risk in communities based on social, medical, and lifestyle risk factors. As a “proof of concept,” I modeled COVID risk in the Massachusetts communities using 29 risk factors, including the prevalence of preexisting comorbid conditions like COPD and social factors such as racial composition. Of the 29 factors, 14 were found to be significant (p < 0.1) indicators: poverty, food insecurity, lack of high school education, lack of health insurance coverage, premature mortality, population, population density, recent population growth, Asian percentage, high-occupancy housing, and preexisting prevalence of cancer, COPD, overweightness, and heart attacks. The machine-learning approach finds the 9 highest risk communities in the state of Massachusetts: Lynn, Brockton, Revere, Randolph, Lowell, New Bedford, Everett, Waltham, and Fitchburg. The 5 most at-risk counties are Suffolk, Middlesex, Bristol, Norfolk, and Plymouth. With appropriate data, the tool could evaluate risk in other communities, or even enumerate individual patient susceptibility. A ranking of communities by risk may help policymakers ensure equitable allocation of limited doses of the COVID vaccine.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author received no financial support for the research, authorship, and/or publication of this article.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe author confirms that the data supporting the findings of this study are available within the article and its supplementary materials.